Legal & General Group PLC Prelude Therapeutics Inc Transaction History
Legal & General Group PLC
- $440 Billion
- Q2 2024
A detailed history of Legal & General Group PLC transactions in Prelude Therapeutics Inc stock. As of the latest transaction made, Legal & General Group PLC holds 962 shares of PRLD stock, worth $2,039. This represents 0.0% of its overall portfolio holdings.
Number of Shares
962
Previous 962
-0.0%
Holding current value
$2,039
Previous $4,000
25.0%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding PRLD
# of Institutions
62Shares Held
33.9MCall Options Held
400Put Options Held
100-
Orbimed Advisors LLC San Diego, CA10.9MShares$23.1 Million1.0% of portfolio
-
Baker Bros. Advisors LP New York, NY10.1MShares$21.5 Million0.51% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY4.13MShares$8.76 Million0.33% of portfolio
-
Boxer Capital, LLC San Diego, CA2.57MShares$5.44 Million0.54% of portfolio
-
Black Rock Inc. New York, NY1.07MShares$2.27 Million0.0% of portfolio
About Prelude Therapeutics Inc
- Ticker PRLD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,369,200
- Market Cap $77.1M
- Description
- Prelude Therapeutics Incorporated, a clinical-stage precision oncology company, focuses on the discovery and development of novel precision cancer medicines to underserved patients. It is developing PRT543 that is in Phase 1 clinical trials in select solid tumors and myeloid malignancies; and PRT811, which is in Phase 1 clinical trials in solid ...